Cargando…
Mutant SOD1 Increases APP Expression and Phosphorylation in Cellular and Animal Models of ALS
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease and it is the most common adult onset neurodegenerative disorder affecting motor neurons. There is currently no effective treatment for ALS and our understanding of the pathological mechanism is still far away from prevention a...
Autores principales: | Rabinovich-Toidman, Polina, Rabinovich-Nikitin, Inna, Ezra, Assaf, Barbiro, Beka, Fogel, Hilla, Slutsky, Inna, Solomon, Beka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658003/ https://www.ncbi.nlm.nih.gov/pubmed/26600047 http://dx.doi.org/10.1371/journal.pone.0143420 |
Ejemplares similares
-
Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALS
por: Rabinovich-Nikitin, Inna, et al.
Publicado: (2016) -
Beneficial Effect of Antibodies against β- Secretase Cleavage Site of App on Alzheimer’s-Like Pathology in Triple-Transgenic Mice
por: Rabinovich-Nikitin, Inna, et al.
Publicado: (2012) -
Inhibition of CXCR4/CXCL12 signaling: a translational perspective for Alzheimer’s disease treatment
por: Gavriel, Yuval, et al.
Publicado: (2021) -
Circadian-Regulated Cardiac Metabolism Involves Transcription Factor E4BP4
por: Rabinovich-Nikitin, Inna, et al.
Publicado: (2023) -
Immunotherapeutic Strategies for Alzheimer's Disease Treatment
por: Solomon, Beka
Publicado: (2009)